Index RUT
P/E 34.57
EPS (ttm) 2.13
Insider Own 2.39%
Shs Outstand 59.42M
Perf Week -5.81%
Market Cap 4.37B
Forward P/E 16.75
EPS next Y 4.39
Insider Trans -4.38%
Shs Float 58.01M
Perf Month -8.70%
Enterprise Value 4.74B
PEG 2.52
EPS next Q 0.83
Inst Own 105.26%
Short Float 6.45%
Perf Quarter -12.92%
Income 128.49M
P/S 2.88
EPS this Y 6.06%
Inst Trans 1.70%
Short Ratio 5.34
Perf Half Y -18.43%
Sales 1.51B
P/B 2.76
EPS next Y 8.00%
ROA 5.03%
Short Interest 3.74M
Perf YTD -16.62%
Book/sh 26.66
P/C 9.74
EPS next 5Y 6.66%
ROE 8.67%
52W High 107.27 -31.49%
Perf Year -29.91%
Cash/sh 7.55
P/FCF 20.25
EPS past 3/5Y 18.04% -
ROIC 5.36%
52W Low 73.60 -0.15%
Perf 3Y 4.88%
Dividend Est. -
EV/EBITDA 14.41
Sales past 3/5Y 9.70% 9.46%
Gross Margin 48.70%
Volatility 3.01% 3.16%
Perf 5Y 33.52%
Dividend TTM -
EV/Sales 3.13
EPS Y/Y TTM 5.03%
Oper. Margin 12.83%
ATR (14) 2.52
Perf 10Y 282.56%
Dividend Ex-Date -
Quick Ratio 2.95
Sales Y/Y TTM 11.84%
Profit Margin 8.48%
RSI (14) 30.03
Recom 1.55
Dividend Gr. 3/5Y - -
Current Ratio 4.34
EPS Q/Q 37.32%
SMA20 -7.74%
Beta 0.61
Target Price 102.00
Payout 0.00%
Debt/Eq 0.52
Sales Q/Q 11.17%
SMA50 -11.15%
Rel Volume 1.50
Prev Close 74.16
Employees 7500
LT Debt/Eq 0.51
Earnings Feb 24 AMC
SMA200 -14.94%
Avg Volume 701.48K
Price 73.49
IPO May 14, 1990
Option/Short Yes / Yes
EPS/Sales Surpr. 8.98% 1.03%
Trades
Volume 1,040,769
Change -0.90%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-26 Downgrade
Wells Fargo
Overweight → Equal Weight
$78
Feb-06-26 Initiated
BTIG Research
Buy
$107
Mar-28-25 Initiated
JP Morgan
Overweight
$120
Dec-11-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$103 → $120
Jun-28-24 Initiated
Robert W. Baird
Outperform
$96
Apr-11-24 Initiated
CL King
Buy
$88
Feb-07-24 Initiated
BofA Securities
Neutral
$87
Dec-21-23 Upgrade
Canaccord Genuity
Hold → Buy
$100
Dec-20-22 Downgrade
Canaccord Genuity
Buy → Hold
$73 → $72
Jan-05-21 Upgrade
Needham
Hold → Buy
$65
Sep-28-20 Upgrade
Wells Fargo
Underweight → Equal Weight
$42
Feb-25-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Feb-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$43
Dec-12-19 Downgrade
Wells Fargo
Market Perform → Underperform
$26
Sep-24-19 Initiated
Oppenheimer
Outperform
Sep-10-19 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-26-19 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-26-19 Downgrade
Needham
Buy → Hold
Oct-02-18 Reiterated
Needham
Buy
$67 → $73
Aug-07-18 Downgrade
BofA/Merrill
Buy → Underperform
Show Previous Ratings
Mar-04-26 10:33PM
Mar-02-26 11:40AM
09:40AM
Feb-27-26 09:45AM
Feb-26-26 08:00AM
11:42PM
Loading…
Feb-25-26 11:42PM
01:55PM
12:08AM
12:04AM
Feb-24-26 08:00PM
07:30PM
04:54PM
(Associated Press Finance)
04:43PM
04:05PM
Feb-22-26 10:09PM
09:19AM
Loading…
Feb-17-26 09:19AM
Feb-16-26 08:54AM
Feb-13-26 03:51PM
09:39AM
Feb-12-26 01:07PM
11:40AM
07:10AM
Feb-11-26 09:55AM
Feb-10-26 01:30PM
11:22AM
08:57AM
Feb-09-26 10:24AM
08:02AM
Feb-06-26 09:45AM
09:41AM
08:07AM
Loading…
08:07AM
Feb-05-26 10:32PM
10:45AM
Feb-04-26 05:25PM
01:55PM
10:23AM
08:47AM
Feb-03-26 11:38AM
Feb-02-26 09:37AM
09:13AM
Jan-29-26 08:02AM
Jan-28-26 07:46AM
07:43AM
07:27AM
07:26AM
Jan-27-26 12:19PM
07:54AM
Jan-26-26 12:10PM
Jan-22-26 12:27PM
Jan-21-26 10:06AM
Jan-08-26 04:05PM
Dec-26-25 11:40AM
Dec-23-25 02:09PM
09:00AM
Dec-18-25 09:50AM
Dec-11-25 11:01PM
Dec-10-25 11:40AM
Nov-24-25 11:40AM
Nov-21-25 06:50PM
12:00PM
Nov-19-25 09:50AM
Nov-13-25 04:05PM
Nov-07-25 11:40AM
Nov-06-25 12:37AM
Nov-05-25 09:00AM
Nov-03-25 09:25AM
Oct-31-25 02:11PM
02:01PM
08:40AM
Oct-30-25 11:04PM
07:30PM
06:20PM
05:24PM
(Associated Press Finance)
05:10PM
04:05PM
Oct-29-25 09:31AM
08:23AM
Oct-28-25 11:17PM
Oct-24-25 01:49PM
Oct-23-25 01:56PM
12:48PM
Oct-22-25 11:40AM
Oct-21-25 07:41AM
Oct-17-25 12:23PM
Oct-16-25 01:12PM
09:45AM
08:57AM
06:32AM
Oct-15-25 04:05PM
01:34PM
08:03AM
Oct-14-25 12:52PM
Oct-13-25 01:11PM
Oct-10-25 10:02AM
10:02AM
08:43AM
08:42AM
Oct-09-25 01:55PM
11:55AM
Oct-08-25 12:47PM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Peterson Neil W. CHIEF OPERATING OFFICER Jan 06 '26 Option Exercise 54.40 5,000 272,000 33,369 Jan 08 12:57 PM Peterson Neil W. CHIEF OPERATING OFFICER Jan 06 '26 Sale 90.00 5,000 450,000 28,369 Jan 08 12:57 PM NEIL W PETERSON Officer Jan 06 '26 Proposed Sale 90.00 5,000 450,000 Jan 06 04:02 PM Lampropoulos Fred P. Executive Chairman Nov 25 '25 Sale 88.04 10,000 880,377 1,019,955 Nov 26 03:22 PM FRED LAMPROPOULOS Director Nov 25 '25 Proposed Sale 88.04 10,000 880,377 Nov 25 04:27 PM Lampropoulos Fred P. Executive Chairman Nov 21 '25 Sale 87.31 25,000 2,182,750 1,029,955 Nov 24 06:00 PM FRED LAMPROPOULOS Director Nov 21 '25 Proposed Sale 87.31 25,000 2,182,631 Nov 21 04:06 PM Lampropoulos Fred P. Executive Chairman Nov 20 '25 Sale 85.13 20,000 1,702,650 1,054,955 Nov 21 10:47 AM Lampropoulos Fred P. Executive Chairman Nov 18 '25 Sale 84.83 5,000 424,130 1,074,955 Nov 20 04:37 PM FRED LAMPROPOULOS Director Nov 20 '25 Proposed Sale 85.13 20,000 1,702,650 Nov 20 04:18 PM FRED LAMPROPOULOS Director Nov 18 '25 Proposed Sale 84.83 5,000 424,130 Nov 18 04:19 PM Lampropoulos Fred P. President and CEO Aug 29 '25 Option Exercise 55.73 159,151 8,869,485 1,204,779 Sep 03 05:26 PM Lampropoulos Fred P. President and CEO Aug 29 '25 Option Exercise 55.73 2,000 111,460 9,734 Sep 03 05:26 PM Ward Lynne N. Director Aug 22 '25 Option Exercise 34.46 3,000 103,380 15,809 Aug 25 12:06 PM Ward Lynne N. Director Aug 22 '25 Sale 88.56 3,000 265,680 12,809 Aug 25 12:06 PM LYNNE WARD Director Aug 22 '25 Proposed Sale 88.56 3,000 265,683 Aug 22 04:07 PM Ward Lynne N. Director Aug 11 '25 Option Exercise 34.46 2,433 83,841 15,242 Aug 12 12:12 PM Ward Lynne N. Director Aug 11 '25 Sale 84.89 2,433 206,536 12,809 Aug 12 12:12 PM LYNNE WARD Director Aug 11 '25 Proposed Sale 84.89 2,433 206,536 Aug 11 04:15 PM Parra Raul Jr. CFO AND TREASURER Jun 13 '25 Option Exercise 59.43 15,181 902,221 39,382 Jun 17 05:57 PM Parra Raul Jr. CFO AND TREASURER Jun 13 '25 Sale 93.75 15,181 1,423,219 24,201 Jun 17 05:57 PM RAUL PARRA Officer Jun 13 '25 Proposed Sale 93.75 15,181 1,423,219 Jun 13 04:04 PM Lampropoulos Fred P. President and CEO Jun 10 '25 Sale 95.61 400 38,244 1,045,628 Jun 12 06:11 PM FRED LAMPROPOULOS Officer Jun 10 '25 Proposed Sale 95.61 400 38,244 Jun 10 04:22 PM Lampropoulos Fred P. President and CEO Jun 05 '25 Sale 95.19 10,000 951,900 1,046,028 Jun 09 02:52 PM FRED LAMPROPOULOS Officer Jun 05 '25 Proposed Sale 95.19 10,000 951,940 Jun 05 04:48 PM McDonnell Michael R. Director Jun 02 '25 Sale 94.51 1,750 165,392 6,395 Jun 03 05:45 PM McDonnell Michael R. Director May 30 '25 Sale 94.30 1,750 165,025 8,145 Jun 03 05:45 PM Floyd David Director May 30 '25 Sale 94.16 3,515 330,972 4,880 Jun 03 05:44 PM Lampropoulos Fred P. President and CEO May 30 '25 Sale 95.12 10,000 951,200 1,056,028 Jun 03 05:43 PM MICHAEL R MCDONNELL Director Jun 02 '25 Proposed Sale 94.51 1,750 165,392 Jun 02 04:05 PM MICHAEL R MCDONNELL Director May 30 '25 Proposed Sale 94.30 1,750 165,025 May 30 04:54 PM FRED LAMPROPOULOS Officer May 30 '25 Proposed Sale 95.12 10,000 951,175 May 30 04:09 PM Floyd David Director May 30 '25 Proposed Sale 96.79 5,021 485,966 May 30 10:25 AM LAMPROPOULOS FRED P President and CEO May 27 '25 Sale 96.54 20,000 1,930,800 1,066,028 May 29 01:46 PM FRED LAMPROPOULOS Officer May 27 '25 Proposed Sale 96.54 20,000 1,930,806 May 27 04:10 PM Millner F. Ann Director May 15 '25 Option Exercise 52.17 21,250 1,108,612 55,793 May 19 06:51 PM Millner F. Ann Director May 15 '25 Sale 96.47 21,250 2,049,988 34,543 May 19 06:51 PM F ANN MILLNER Director May 15 '25 Proposed Sale 96.47 21,250 2,050,083 May 15 04:04 PM Peterson Neil CHIEF OPERATING OFFICER Apr 01 '25 Option Exercise 54.40 5,000 272,000 33,369 Apr 02 04:54 PM Peterson Neil CHIEF OPERATING OFFICER Apr 01 '25 Sale 104.53 5,000 522,650 28,369 Apr 02 04:54 PM NEIL W PETERSON Officer Apr 01 '25 Proposed Sale 104.53 5,000 522,668 Apr 01 04:19 PM Wright Joseph Officer Mar 25 '25 Proposed Sale 105.00 10,000 1,050,000 Mar 25 05:34 PM